Search Weight Loss Topics:

Home » Uncategorized » Weight loss drugs like Wegovy and Ozempic may influence how food tastes, study finds – WDSU New Orleans

CHRISTOPHER SALAS WCVB NEWSCENTER FIVE. ALL RIGHT. THERE IS A NEW STUDY THAT SHOWS THE MAIN INGREDIENT IN OZEMPIC AND WEGOVY, WHICH ALREADY HELP WITH DIABETES AND WEIGHT LOSS. MAY DRACUT RADICALLY CUT THE RISKS FROM CHRONIC KIDNEY DISEASE. WE WERE JUST TALKING ABOUT THIS HERE. TO TALK MORE ABOUT IT IS DOCTOR TODD ELLERIN. OF COURSE, WITH SOUTH SHORE HEALTH. ITS SO INTERESTING BECAUSE IN SOME CASES ITS THESE THESE DRUGS GET A BAD RAP BECAUSE PEOPLE GET SICK AND BUT YOURE A DOCTOR, YOU SEE THEM IN A TOTALLY DIFFERENT LIGHT. THIS RESEARCH SHOWS THAT. AND IM GOING TO TRY TO GET THE RIGHT NAME. RIGHT. IS IT SEMAGLUTIDE? THATS EXACTLY OKAY. ITS THE MAIN INGREDIENT IN THOSE DRUGS. AND IT HAD A 24% LOWER RISK OF MAJOR KIDNEY DISEASE ISSUES. UM, PEOPLE WHO ARE IN DIALYSIS, WHO ARE ON DIALYSIS OR THEY NEED A KIDNEY TRANSPLANT. THATS SIGNIFICANT. THIS IS REALLY SIGNIFICANT. MARIA WHAT WERE SEEING IS NOT JUST WEVE ALREADY SEEN THESE DRUGS, SEMAGLUTIDE DECREASE, THIS DIABETES DECREASE WEIGHT LOSS. YOU KNOW, SIGNIFICANT WEIGHT LOSS ALSO HEART FAILURE DEATH FROM THIS. BUT IN THIS STUDY, LARGE STUDY 3500 PATIENTS INTERNATIONAL RANDOMIZED HALF WERE GIVEN AN INJECTION OF OZEMPIC ONE MILLIGRAM ONCE A WEEK. THE OTHER PLACEBO. AND WHAT THEY SHOWED WAS THERE WAS A SIGNIFICANT DECREASE IN NOT ONLY KIDNEY DISEASE AND KIDNEY FAILURE, BUT ALSO CARDIOVASCULAR DISEASE AND DEATH. DEATH FROM ALL CAUSES. ITS A BIG DEAL, BUT YOU NEED TO HAVE A PRESCRIPTION FOR THIS. SO TRUE. AND YOU NEED TO HAVE THESE ISSUES TO GET THAT PRESCRIPTION CORRECT. IN THIS STUDY. THESE WERE ALL PATIENTS WITH TYPE TWO DIABETES OKAY. AND CHRONIC KIDNEY DISEASE. SO YOU HAD TO HAVE BOTH FOR THIS STUDY. ALL RIGHT. SO THIS IS THE LATEST STUDY TO TO TALK ABOUT THIS ADDED BENEFIT FROM THE DRUGS. ITS NEW. THEYRE NEW. YOU HAVE TO ADMIT THAT THEYRE NEW. SO HOW DO WE KNOW ABOUT LONG TERM EFFECTS. LOOK I THINK THEYRE NEW BUT THEYRE STILL WEVE SEEN THIS OVER YEARS AND WEVE SEEN MULTIPLE DRUGS FROM DIFFERENT CLASSES. AND AND WHAT WERE SEEING IS GI SIDE EFFECTS ARE THE MOST COMMON. AND THEN THERE ARE OTHER RARE SIDE EFFECTS. BUT REALLY THE BENEFITS ARE JUST SIGNAL SHIRLEY OUTSTRIPPING THE RISKS. THATS SO INTERESTING. IT IS. WE HAVE WE HAVE TO POINT OUT, BY THE WAY, THIS TRIAL WAS FUNDED BY NOVO NORDISK. THATS THE COMPANY THAT MAKES OZEMPIC. SO WE ALWAYS HAVE TO PUT THAT IN PERSPECTIVE. SHOULD THAT CHANGE HOW WE LOOK AT THESE RESULTS? I DONT THINK SO. AND Y YOU HEARD ME SAY BEFORE, ITS NOT JUST THIS PHARMACEUTICAL COMPANY WITH SEMAGLUTIDE, BUT THERES OTHER COMPANIES LIKE ELI LILLY HAS ANOTHER APPETITE. AND WERE SEEING THE SAME BENEFITS AGAIN. AND AGAIN. DIFFERENT COMPANIES, NOT JUST IN DIABETICS, BUT IN PATIENTS WHO ARE OBESE. WERE SEEING DECREASES IN HEART FAILURE, HEART ATTACKS, STROKES. AND REMEMBER SOMETHING THIS GLP AGONISTS RIGHT. THESE RECEPTORS ARE NOT JUST ON THE HEART AND THE KIDNEY AND THE PANCREAS, BUT WERE ALSO SEEING IT IN THE BRAIN. SO YOU CAN IMAGINE STUDIES ARE ALSO GOING TO BE DONE IN ALZHEIMERS DISEASE. ADDICTION. WE HAVE TO WAIT TO SEE. BUT SO FAR VERY PROMISING. WOW. SO INTERESTING. WEVE RUN OUT OF TIME. BUT ID LOVE TO EXPLORE MORE BECAUSE THERE ARE PEOPLE WHO ARE TAKING THIS AND AND THEYRE IN THE OFF MARKET AND THEY SHOULDNT BE TAKING IT. THATS A DIFFERENT STORY, RIGHT? AND THATS A DIFFERENT STORY THAT WERE TALKING ABOUT THESE HEALTH BENEFITS WITH A DOCTOR. SO VERY INTERESTING. ENJO

Weight loss drugs like Wegovy and Ozempic may influence how food tastes, study finds

Updated: 12:43 PM CDT Jun 18, 2024

The buzz around semaglutide, the main active ingredient in Ozempic and Wegovy, shows no signs of quieting anytime soon. In fact, interest is on the rise and anecdotal side effects of these Glucagon-Like Peptide 1 (GLP-1) medications are still coming to light.Video above: Can Ozempic, Wegovy cut chronic kidney disease risk?You may have heard about Ozempic butt, Ozempic face, and even Ozempic personality. Now, a new small study indicates that these types of medications may influence peoples sense of taste.The study, presented at ENDO 2024, (the Endocrine Societys annual meeting in Boston, MA) looked into how semaglutide might impact taste sensitivity. Its important to point out that this study has not yet been peer-reviewed or published in a medical journal, and only looked at 30 women.Previous research has shown that people with obesity often perceive tastes less intensely, and they have an inherently elevated desire for sweet and energy-dense food, Mojca Jensterle Sever, Ph.D., study author, said in a press release. Our findings build upon preliminary animal studies showing that central administration of GLP-1 medications impacts taste aversion to sweetness, Jensterle Sever noted. GLP-1 agonists are a class of drugs that mimic the effects of the bodys natural GLP-1 hormone (which stimulates insulin secretion and inhibits glucagon release) and are used to treat type 2 diabetes and obesity.Researchers recruited 30 women with an average age of 34. Half of the participants took semaglutide once weekly; the other half took a placebo. At the beginning and end of the 16-week study, the scientists measured three things:Taste sensitivity: Measured using strips infused with the four basic tastessweet, sour, salty, and bitter.Gene expression: Evaluated by taking biopsies of participants tongues to see which information encoded in a gene is turned into a function. Brain responses: Evaluated by a functional MRI scan while a sweet solution dripped onto their tongue before and after a meal.The results of the study revealed that those taking semaglutide were more sensitive to tastes than those taking a placebo. Researchers found that the tongue biopsies showed increased activity of genes associated with taste signaling transduction pathways, neural plasticity, and renewal of taste buds in the tongue, in those who took semaglutide. Lastly, the brain scans demonstrated that, in response to tasting a sweet solution, there was increased activity in the angular gyrus of the parietal cortexa part of the brain that influences language and number processing, memory, and reasoning. This shift in a persons concept of reward compared with neutral feelings toward taste could have significance for understanding and potentially adjusting taste preferences in people with obesity, per the press release.So, how can GLP-1 agonist drugs like Ozempic and Wegovy influence taste? According to Deena Adimoolam, M.D., board-certified endocrinologist and a member of Preventions Medical Review Board, we have known that GLP-1s impact taste sensitivity for quite some time. This is done through a variety of complex mechanisms and interactions between GLP1 and various parts of the body, she explains, such as:GLP-1 is produced by the taste buds themselvesGLP-1 is produced in the gut, which may be influenced by taste, especially the perception of sweet taste GLP-1 is produced in the brain, which is also influenced by tasteStudies have shown that people on GLP-1 drugs report changes in their cravings for certain foods, including sweets and rich or fatty foods, which could certainly be related to a (negative) change in the way they perceive these foods on the taste buds, says Avantika Waring, M.D., endocrinologist and chief medical officer at 9amHealth. And if foods arent perceived by the brain as tasty, then it makes sense that people would crave them less, and consume less of them, she explains.If patients are satisfied with food that is less sweet, or satisfied with a smaller amount of sweet food, this could significantly impact their caloric intake and have a potent effect on their weight loss, agrees Meghan Garcia-Webb, M.D., triple board-certified in internal medicine, lifestyle medicine, and obesity medicine physician and internist at Beth Israel Lahey Health. Patients on semaglutide tend to find it is easier to stop eating when they are satisfied. They also tend to be more satisfied even though portions are smaller. They also dont crave food as much, if at all. So part of this increased satisfaction with meals may be tied to better sensory perception, including enhanced ability to taste sweetness, Dr. Garcia-Webb explains. Hence, GLP-1 drug users getting more of a sensory reward with less calories.As of now, we dont know if these changes to taste sensitivity are permanent, says Dr. Waring, And the data we have to date suggests that when the drugs are stopped, the effect of the drug also reverses when it comes to weight loss. However, the changes the researchers noted were related to gene expression, a process by which information encoded in a gene is turned into a function, such as turning protein production on and off. So, it is likely that it isnt permanent but more related to the impact of the drug, Dr. Waring explains.The bottom lineThere are important limitations to consider with this study, Dr. Adimoolam points out. The sample size was small, the study does not reflect the way the general population with obesity eats and lives day-to-day, and we do not know these changes actually have a true impact on taste, she says.The science of taste, food cravings, preferences, drive to eat, and weight gain are complex, says Dr. Waring. Its exciting that we have medications that can help people who have obesity-related health conditions to lose weight and improve their health, but we still dont know all the ways in which they work. These results are important because they add to the growing body of evidence that GLP-1 medications work in a variety of ways to target the underlying causes of obesity, including taste perception, she notes.Its also important to know that some may change your perception of sweet tastes without medication, says Dr. Adimoolam. You can do it with lifestyle and behavioral changes on your own, she says. If you feel that you consume too much sugar, consider cutting back on your sugar intake each week gradually over weeks to months and over time your bodys perception of taste will change, she advises. Still, some people may need medications, and others may not. If youre wondering if a semaglutide drug like Ozempic or Wegovy is right for you, to talk to your doctor who can best advise you on the best course of action.

The buzz around semaglutide, the main active ingredient in Ozempic and Wegovy, shows no signs of quieting anytime soon. In fact, interest is on the rise and anecdotal side effects of these Glucagon-Like Peptide 1 (GLP-1) medications are still coming to light.

Video above: Can Ozempic, Wegovy cut chronic kidney disease risk?

You may have heard about Ozempic butt, Ozempic face, and even Ozempic personality. Now, a new small study indicates that these types of medications may influence peoples sense of taste.

The study, presented at ENDO 2024, (the Endocrine Societys annual meeting in Boston, MA) looked into how semaglutide might impact taste sensitivity. Its important to point out that this study has not yet been peer-reviewed or published in a medical journal, and only looked at 30 women.

Previous research has shown that people with obesity often perceive tastes less intensely, and they have an inherently elevated desire for sweet and energy-dense food, Mojca Jensterle Sever, Ph.D., study author, said in a press release.

Our findings build upon preliminary animal studies showing that central administration of GLP-1 medications impacts taste aversion to sweetness, Jensterle Sever noted.

GLP-1 agonists are a class of drugs that mimic the effects of the bodys natural GLP-1 hormone (which stimulates insulin secretion and inhibits glucagon release) and are used to treat type 2 diabetes and obesity.

Researchers recruited 30 women with an average age of 34. Half of the participants took semaglutide once weekly; the other half took a placebo. At the beginning and end of the 16-week study, the scientists measured three things:

The results of the study revealed that those taking semaglutide were more sensitive to tastes than those taking a placebo. Researchers found that the tongue biopsies showed increased activity of genes associated with taste signaling transduction pathways, neural plasticity, and renewal of taste buds in the tongue, in those who took semaglutide. Lastly, the brain scans demonstrated that, in response to tasting a sweet solution, there was increased activity in the angular gyrus of the parietal cortexa part of the brain that influences language and number processing, memory, and reasoning.

This shift in a persons concept of reward compared with neutral feelings toward taste could have significance for understanding and potentially adjusting taste preferences in people with obesity, per the press release.

So, how can GLP-1 agonist drugs like Ozempic and Wegovy influence taste? According to Deena Adimoolam, M.D., board-certified endocrinologist and a member of Preventions Medical Review Board, we have known that GLP-1s impact taste sensitivity for quite some time. This is done through a variety of complex mechanisms and interactions between GLP1 and various parts of the body, she explains, such as:

Studies have shown that people on GLP-1 drugs report changes in their cravings for certain foods, including sweets and rich or fatty foods, which could certainly be related to a (negative) change in the way they perceive these foods on the taste buds, says Avantika Waring, M.D., endocrinologist and chief medical officer at 9amHealth. And if foods arent perceived by the brain as tasty, then it makes sense that people would crave them less, and consume less of them, she explains.

If patients are satisfied with food that is less sweet, or satisfied with a smaller amount of sweet food, this could significantly impact their caloric intake and have a potent effect on their weight loss, agrees Meghan Garcia-Webb, M.D., triple board-certified in internal medicine, lifestyle medicine, and obesity medicine physician and internist at Beth Israel Lahey Health. Patients on semaglutide tend to find it is easier to stop eating when they are satisfied. They also tend to be more satisfied even though portions are smaller. They also dont crave food as much, if at all. So part of this increased satisfaction with meals may be tied to better sensory perception, including enhanced ability to taste sweetness, Dr. Garcia-Webb explains. Hence, GLP-1 drug users getting more of a sensory reward with less calories.

As of now, we dont know if these changes to taste sensitivity are permanent, says Dr. Waring, And the data we have to date suggests that when the drugs are stopped, the effect of the drug also reverses when it comes to weight loss. However, the changes the researchers noted were related to gene expression, a process by which information encoded in a gene is turned into a function, such as turning protein production on and off. So, it is likely that it isnt permanent but more related to the impact of the drug, Dr. Waring explains.

There are important limitations to consider with this study, Dr. Adimoolam points out. The sample size was small, the study does not reflect the way the general population with obesity eats and lives day-to-day, and we do not know these changes actually have a true impact on taste, she says.

The science of taste, food cravings, preferences, drive to eat, and weight gain are complex, says Dr. Waring. Its exciting that we have medications that can help people who have obesity-related health conditions to lose weight and improve their health, but we still dont know all the ways in which they work. These results are important because they add to the growing body of evidence that GLP-1 medications work in a variety of ways to target the underlying causes of obesity, including taste perception, she notes.

Its also important to know that some may change your perception of sweet tastes without medication, says Dr. Adimoolam. You can do it with lifestyle and behavioral changes on your own, she says. If you feel that you consume too much sugar, consider cutting back on your sugar intake each week gradually over weeks to months and over time your bodys perception of taste will change, she advises. Still, some people may need medications, and others may not. If youre wondering if a semaglutide drug like Ozempic or Wegovy is right for you, to talk to your doctor who can best advise you on the best course of action.

Read the rest here:
Weight loss drugs like Wegovy and Ozempic may influence how food tastes, study finds - WDSU New Orleans

Your Full Name
Your Email
Your Phone Number
Select your age (30+ only)	30313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120
Select Your US State	Select Your StateAlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWashington,DCWest VirginiaWisconsinWyoming
Program Choice	Select Your ProgramInjectable HGHInjectable TestoteroneInjectable SermorelinInjectable Weight LossInjectable HCG DietInjectable Vitamins
Confirm over 30 years old	Yes
Confirm that you resident in USA	Yes
This is a Serious Inquiry	Yes
Message:

Home » Uncategorized » Weight loss drugs like Wegovy and Ozempic may influence how food tastes, study finds – WDSU New Orleans